Status:
RECRUITING
Scottish Advanced Fetal Research Study
Lead Sponsor:
University of Aberdeen
Collaborating Sponsors:
NHS Grampian
Conditions:
Fetal Developmental Abnormality
Fetal Development
Eligibility:
All Genders
16+ years
Brief Summary
In-utero exposure to drugs and chemicals through maternal smoking, alcohol use, drug abuse, prescription medicines and occupational/lifestyle exposures is widespread. Such exposures can alter fetal de...
Detailed Description
Primary Objective To provide fundamental information to better understand the mechanisms involved and to detect and treat or ameliorate adverse effects during pregnancy. Secondary Objectives The se...
Eligibility Criteria
Inclusion Criteria:
- Women at 7-20 weeks of gestation (critical stage of fetal development).
- Women aged 16 years and older, deemed capable of making a rational decision.
- Absence of fetal anomaly at ultrasound scan (only normal fetuses are required).
- Women who are fluent English speakers. This is in order to ensure the woman understands that fetal tissues will be collected.
Exclusion Criteria:
- Women exhibiting considerable emotional distress.
- Fetal anomalies identified at ultrasound scan.
Key Trial Info
Start Date :
May 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2025
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT04613583
Start Date
May 1 2016
End Date
October 1 2025
Last Update
December 11 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Aberdeen
Aberdeen, United Kingdom, AB25 2ZD